South Korean Government Turns to Blockchain Tech to More Securely Store Clinical Diabetes Data

Seoul, South Korea. (Shutterstock)

The South Korean government wants to develop a blockchain registry to help analyze, anonymize and store clinical data for diabetes.

Blockchain startup Sendsquare has been selected by the government to develop a proof-of-concept project for the nation, which has around 3.6 million people with diabetes, the company announced on Friday.

The startup will team with clinical experts and practitioners from Seoul’s KyungHee University Medical Center to begin analyzing nine years’ worth of diabetes clinical data previously collected by the center.

Related: Binance-Backed Blockchain Auditing Firm Partners With Hdac to Track Internet-of-Things Devices

“Storing and collaborating work across a large volume of data using centralized services has proven unwieldy and subject to issues of data loss, duplication and manipulation,” according to KyungHee Medical Center’s Professor Suk Chon.

Sendsquare’s blockchain “can help us to solve data storage problems, and in the long term help diabetes sufferers nationally,” the professor said in a press statement.

The project will take an estimated six months to complete, with the initial objective to analyze the data working to anonymize it before finally implementing the data onto a registry which will be recorded on the FLETA blockchain platform.

See also: South Korean Central Bank Accelerates Digital Currency Pilot to Keep Up With Other Nations

Related: Base Layer Wars Heat Up With Another $12M Committed to AVA Labs’ Avalanche Blockchain

After the blockchain application has been developed, Sendsquare will seek independent verification from Korea’s Telecommunications Technology Association (TTA).

Sendsquare is a blockchain startup responsible for the development of the South Korea-based FLETA blockchain which was previously charged with building a proof-of-concept network for the nation’s healthcare system.

Related Stories

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.